Carotid endarterectomy for stroke prevention revisited

Mark Eskandari*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Since its original description, more than 50 years ago, carotid endarterectomy (CEA) has been challenged in its success in achieving adequate stroke prevention among both symptomatic and asymptomatic patients with cervical carotid stenosis. CEA remains the most common vascular surgical operation performed today, however, its future has been called into question with the introduction of percutaneous carotid angioplasty and stenting, more effective antiplatelet agents (i.e., clopidogrel), cholesterol-lowering agents (i.e., statins) and angiotensin-converting enzyme inhibitors. The focus of this article is to review the notable trials substantiating the efficacy of CEA, indications for surgery and technical components that have refined expected favorable outcomes.

Original languageEnglish (US)
Pages (from-to)935-938
Number of pages4
JournalExpert Review of Neurotherapeutics
Issue number8
StatePublished - Aug 1 2007


  • Carotid endarterectomy
  • Eversion
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • General Neuroscience


Dive into the research topics of 'Carotid endarterectomy for stroke prevention revisited'. Together they form a unique fingerprint.

Cite this